Clinical Trials in San Diego

Showing 4001-4020 of 13,015 trials

Saypha® VOLUME Lidocaine for Midface Augmentation

NCT05386030

The clinical investigation is a randomized, subject- and evaluator-blinded, active treatment controlled, multicenter, clinical investigation, to demonstrate the non inferiority of saypha® VOLUME Lidocaine to one of the devices approved for the same indication (Juvéderm® Voluma™ XC).

Moderate to Severe Midface Volume Deficit

Croma-Pharma GmbH562 participantsStarted Aug 2022

Scottsdale, Arizona, United States • Encino, California, United States • Fremont, California, United States +13 more locations

COMPLETEDPhase 2< 1 mile

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

NCT05203341

The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo in participants with MDD on improving symptoms of depression.

Major Depressive Disorder

Neurocrine Biosciences183 participantsStarted Feb 2022

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Riverside, California, United States +38 more locations

Saypha® VOLUME Lidocaine for Midface Augmentation

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

Find Trials by Condition in San Diego

Communities Fighting COVID Return to School

The Healthy Elderly Longevity Cohort

The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

CLUSTER Trial for Outbreak Detection and Response

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

The Syn-Sleep Study

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Non-Complex Biliary Stones DSC vs ERC

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Nemaline Myopathy Clinical Research Network (NM-CTRN)

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)